Terms: = Pancreatic cancer AND CUX1, ENSG00000160967, P39880, p75, p200, p110, p100, Nbla10317, CUX, COY1, CDP, CASP, 1523 AND Prognosis
9 results:
1. Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs.
Matsuda Y; Yamashita T; Ye J; Yasukawa M; Yamakawa K; Mukai Y; Machitani M; Daigo Y; Miyagi Y; Yokose T; Oshima T; Ito H; Morinaga S; Kishida T; Minamoto T; Yamada S; Takei J; Kaneko MK; Kojima M; Kaneko S; Masaki T; Hirata M; Haba R; Kontani K; Kanaji N; Miyatake N; Okano K; Kato Y; Masutomi K
J Pathol; 2022 Jun; 257(2):172-185. PubMed ID: 35094384
[TBL] [Abstract] [Full Text] [Related]
2. Pan-cancer analysis of the casp gene family in relation to survival, tumor-infiltrating immune cells and therapeutic targets.
Hong W; Gu Y; Guan R; Xie D; Zhou H; Yu M
Genomics; 2020 Nov; 112(6):4304-4315. PubMed ID: 32682809
[TBL] [Abstract] [Full Text] [Related]
3. The prognostic value of microRNA-183 in human cancers: A meta-analysis.
Zhang XL; Pan SH; Yan JJ; Xu G
Medicine (Baltimore); 2018 Jun; 97(26):e11213. PubMed ID: 29952976
[TBL] [Abstract] [Full Text] [Related]
4. cux1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasms.
Krug S; Kühnemuth B; Griesmann H; Neesse A; Mühlberg L; Boch M; Kortenhaus J; Fendrich V; Wiese D; Sipos B; Friemel J; Gress TM; Michl P
Endocr Relat Cancer; 2014; 21(6):879-90. PubMed ID: 25248790
[TBL] [Abstract] [Full Text] [Related]
5. [Surgical treatment of pancreatic adenocarcinoma using cephalic duodenopancreatectomy (Part 2). Long term follow up after 204 cases].
Fabregat J; Busquets J; Peláez N; Jorba R; García-Borobia F; Masuet C; Valls C; Ruiz-Osuna S; Serrano T; Galán M; Cambray M; Laquente B; Ramos E; Rafecas A
Cir Esp; 2010 Dec; 88(6):374-82. PubMed ID: 21030012
[TBL] [Abstract] [Full Text] [Related]
6. pancreatic cancer: progress made.
Simianu VV; Zyromski NJ; Nakeeb A; Lillemoe KD
Acta Oncol; 2010 May; 49(4):407-17. PubMed ID: 20059311
[TBL] [Abstract] [Full Text] [Related]
7. Carcinoma of the body of pancreas in evolution: an aggressive disease affecting younger patients?
Dickinson KJ; Gomez D; Lowe A; Gokhale JA; Ausobsky JR; Guillou PJ; Rahman SH
JOP; 2007 May; 8(3):312-9. PubMed ID: 17495360
[TBL] [Abstract] [Full Text] [Related]
8. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
Zhang Y; Dang C; Ma Q; Shimahara Y
Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
[TBL] [Abstract] [Full Text] [Related]
9. Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells.
Zhu Z; Kleeff J; Kayed H; Wang L; Korc M; Büchler MW; Friess H
Mol Carcinog; 2002 Nov; 35(3):138-47. PubMed ID: 12410565
[TBL] [Abstract] [Full Text] [Related]
